financetom
Business
financetom
/
Business
/
MGM's LeoVegas Hits The Jackpot, Acquires Tipico's U.S. Sportsbook And Online Casino
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MGM's LeoVegas Hits The Jackpot, Acquires Tipico's U.S. Sportsbook And Online Casino
Jun 24, 2024 5:21 AM

MGM Resorts International ( MGM ) shares are trading slightly higher in premarket today.

The entertainment company announced that its subsidiary, LeoVegas Group, has agreed to acquire the U.S. sportsbook and online casino platform from Tipico Group Ltd.

This strategic move marks LeoVegas’ second major investment, following its acquisition of game developer Push Gaming in 2023.

The deal aims to enhance LeoVegas’ ability to operate a proprietary sportsbook globally, with the exception of the BetMGM joint venture.

Tipico will cease its U.S. operations before the acquisition’s completion. As part of the agreement, LeoVegas will take over certain U.S.-focused management, technology, and trading teams from Tipico across the U.S., Colombia, and Europe.

This acquisition is expected to boost MGM Resorts’ global digital gaming presence by providing a proprietary sports betting platform.

Gustaf Hagman, CEO of LeoVegas, said “By controlling our own sportsbook technology, we ensure that we will deliver the world’s greatest iGaming experience to customers across all our markets and brands.”

“Powering our strong brands with a competitive and innovative sports product will enable us to grow and strengthen our sportsbook offering in both new and existing markets.”

The transaction is subject to customary closing conditions and is expected to be finalized in the third quarter of 2024. MGM held $2.7 billion in cash and equivalents as of March-end.

Price Action: MGM shares are trading higher by 0.24% at $42.10 in premarket at last check Monday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OceanaGold Closes Sale of Interest in Blackwater Project for $30 Million in Cash
OceanaGold Closes Sale of Interest in Blackwater Project for $30 Million in Cash
Jun 24, 2024
07:55 AM EDT, 06/24/2024 (MT Newswires) -- OceanaGold ( OCANF ) on Monday closed the sale of the company's interest in the Blackwater project in New Zealand for $30 million in cash. The company expects to record an after-tax accounting gain of about $10 million in the second quarter. The company closed the deal after receiving all required regulatory approvals...
MGM's LeoVegas Hits The Jackpot, Acquires Tipico's U.S. Sportsbook And Online Casino
MGM's LeoVegas Hits The Jackpot, Acquires Tipico's U.S. Sportsbook And Online Casino
Jun 24, 2024
MGM Resorts International ( MGM ) shares are trading slightly higher in premarket today. The entertainment company announced that its subsidiary, LeoVegas Group, has agreed to acquire the U.S. sportsbook and online casino platform from Tipico Group Ltd. This strategic move marks LeoVegas’ second major investment, following its acquisition of game developer Push Gaming in 2023. The deal aims to...
Oncolytics Biotech President and CEO Coffey to Take Medical Leave of Absence
Oncolytics Biotech President and CEO Coffey to Take Medical Leave of Absence
Jun 24, 2024
07:56 AM EDT, 06/24/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) on Monday said President and Chief Executive Officer Matt Coffey will take a medical leave of absence, effective immediately. Wayne Pisano, chair of Oncolytics' board, will serve as the interim CEO during Dr. Coffey's absence, a statement said. Pisano, who has chaired the board since 2013, has 30...
Top Premarket Decliners
Top Premarket Decliners
Jun 24, 2024
07:56 AM EDT, 06/24/2024 (MT Newswires) -- G1 Therapeutics ( GTHX ) shares slumped nearly 55% Monday premarket after the company said its treatment candidate for metastatic triple negative breast cancer failed to achieve statistical significance in a late-stage trial and that it will wind down the program. BitFuFu ( FUFU ) shares retreated 21%, paring Friday's rally. ResMed (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved